We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
-17.3%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
–
AUM
$76.5M
AUM Growth
-$86.6M
Cap. Flow
-$70.3M
Cap. Flow %
-91.79%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
THOR
Synthorx, Inc. Common Stock
THOR
+$70.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAT icon
1
Phathom Pharmaceuticals
PHAT
$708M
$53.4M 69.76%
2,067,861
– –
MRUS
2
DELISTED
Merus
MRUS
$19.4M 25.3%
1,600,000
– –
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.78M 4.94%
1,570,000
– –
THOR
4
DELISTED
Synthorx, Inc. Common Stock
THOR
– –
-1,005,184
Closed -$70.3M

Similar funds

BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
FFS
Forge Financial Services Edmond, Oklahoma $987M AUM 14.12% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Medicxi Ventures Management's Q1 2020 Portfolio in Review

As of Q1 2020, Medicxi Ventures Management held 4 positions worth $76.5M, down 53% from $163M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Medicxi Ventures Management withdrew a net $70.3M in Q1 2020, closing 1 position. Its most notable exit was Synthorx, Inc. Common Stock, an estimated $70.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management fully exited Synthorx, Inc. Common Stock in Q1 2020, selling an estimated $70.3M.
  • Medicxi Ventures Management's ten largest holdings make up 100% of its $76.5M portfolio in Q1 2020.
  • Medicxi Ventures Management opened 0 new positions and closed 1 in Q1 2020.
  • Medicxi Ventures Management's portfolio value fell 53% quarter-over-quarter to $76.5M.

Based on Medicxi Ventures Management's 13F filing for Q1 2020, filed 12 May 2020.